- Home
- LXU vs ITOS Comparison
LXU vs ITOS Comparison
Compare LXU & ITOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LXU
- ITOS
- Stock Information
- Founded
- LXU 1968
- ITOS 2011
- Country
- LXU United States
- ITOS United States
- Employees
- LXU 586
- ITOS N/A
- Industry
- LXU Major Chemicals
- ITOS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LXU Industrials
- ITOS Health Care
- Exchange
- LXU Nasdaq
- ITOS Nasdaq
- Market Cap
- LXU 533.6M
- ITOS 568.2M
- IPO Year
- LXU 1969
- ITOS 2020
- Fundamental
- Price
- LXU $7.43
- ITOS $12.16
- Analyst Decision
- LXU Buy
- ITOS Strong Buy
- Analyst Count
- LXU 4
- ITOS 5
- Target Price
- LXU $9.69
- ITOS $32.60
- AVG Volume (30 Days)
- LXU 305.2K
- ITOS 465.8K
- Earning Date
- LXU 10-30-2024
- ITOS 11-05-2024
- Dividend Yield
- LXU N/A
- ITOS N/A
- EPS Growth
- LXU N/A
- ITOS N/A
- EPS
- LXU 0.03
- ITOS N/A
- Revenue
- LXU $525,177,000.00
- ITOS $35,000,000.00
- Revenue This Year
- LXU N/A
- ITOS $271.18
- Revenue Next Year
- LXU $6.75
- ITOS N/A
- P/E Ratio
- LXU $271.11
- ITOS N/A
- Revenue Growth
- LXU N/A
- ITOS N/A
- 52 Week Low
- LXU $6.74
- ITOS $8.20
- 52 Week High
- LXU $10.83
- ITOS $18.75
- Technical
- Relative Strength Index (RSI)
- LXU 43.46
- ITOS 35.73
- Support Level
- LXU $6.91
- ITOS $15.63
- Resistance Level
- LXU $7.99
- ITOS $17.63
- Average True Range (ATR)
- LXU 0.23
- ITOS 0.96
- MACD
- LXU -0.01
- ITOS -0.17
- Stochastic Oscillator
- LXU 42.11
- ITOS 19.22
About LXU LSB Industries Inc.
LSB Industries Inc is engaged in the manufacturing and sale of chemical products in the United States. The company manufactures and sells chemical products for the agricultural, industrial, and mining markets. Its products include ammonia, fertilizer grade ammonium nitrate (AN and HDAN), and urea ammonia nitrate (UAN) for agricultural applications; high purity and commercial grade ammonia, sulfuric acids, concentrated, blended, and regular nitric acid, mixed nitrating acids, carbon dioxide, and diesel exhaust fluid for industrial applications; and industrial grade AN (LDAN) and AN solutions for mining applications. Its products are sold through distributors and directly to end customers throughout the United States and other parts of North America.
About ITOS iTeos Therapeutics Inc.
ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.